Literature DB >> 8763336

Antitopoisomerase drug action and resistance.

J L Nitiss1, W T Beck.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8763336     DOI： 10.1016/0959-8049(96)00056-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  25 in total

1.  Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

Authors:  T A Järvinen; M Tanner; V Rantanen; M Bärlund; A Borg; S Grénman; J Isola
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 4.  The unfolded protein response and cancer: a brighter future unfolding?

Authors:  Peter Scriven; Nicola J Brown; A Graham Pockley; Lynda Wyld
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

5.  Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.

Authors:  U G Bhat; P Raychaudhuri; W T Beck
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

Authors:  J Arends; C Unger
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

Review 7.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

8.  Topoisomerase assays.

Authors:  John L Nitiss; Eroica Soans; Anna Rogojina; Aman Seth; Margarita Mishina
Journal:  Curr Protoc Pharmacol       Date:  2012-06

9.  Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.

Authors:  Nathalie Vilain; Monika Tsai-Pflugfelder; Audrey Benoit; Susan M Gasser; Didier Leroy
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

10.  DNA repair functions that control sensitivity to topoisomerase-targeting drugs.

Authors:  Mobeen Malik; John L Nitiss
Journal:  Eukaryot Cell       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.